Teva Pharmaceuticals isn’t the only life sciences company to impact New Jersey’s office market this year, as several others have inked sizable leases to expand or upgrade their space.
Despite new blocks of space hitting the market, New Jersey saw a long-overdue surge of large office leases in the second quarter — with signs that more are on the way.
A global medical technology maker has proposed relocating within Plainsboro to a nearly 167,000-square-foot building once occupied by Novo Nordisk, thanks in part to a 10-year, $17.8 million tax credit approved last week by state officials.